The existing cancer drug vorinostat has been shown to kill resistant cancer cells in skin cancer patients, according to a study published in Cell. The drug can be used on patients who have a resistance to treatment with a BRAF inhibitor.
Researchers discover new strategy against drug-resistant skin cancer
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.